This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts, Eberhard Karls Universität Tuebingen Medizinische Fakultaet, Eberhard-Karls-Universitaet Tuebingen Universitaetsklinikum. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 20 
1 out of 1 
1 out of 16 
Years Active: 2017-2021
Title: Sorin Armeanu-Ebinger: Innovator in Tumor Treatment
Introduction
Sorin Armeanu-Ebinger is a notable inventor based in Tuebingen, Germany. He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for tumor diseases. With a total of 2 patents, his work focuses on advancing therapeutic options for patients suffering from various forms of cancer.
Latest Patents
One of his latest patents is titled "Tumor marker for the rhabdomyosarcoma." This invention relates to a nucleic acid molecule that encodes a splice variant of the human P2RX7 receptor. It includes nucleic acid molecules derived from this receptor, a recombinant vector containing these molecules, and a host that expresses the encoded polypeptide. Additionally, it encompasses a binding molecule that interacts with the polypeptide, a pharmaceutical composition containing this binding molecule, and methods for producing the isolated polypeptide.
Another significant patent is "Genetically modified paramyxovirus for treatment of tumor diseases." This invention involves a genetically modified Paramyxovirus and a pharmaceutical composition that includes this virus. It outlines the use of the modified Paramyxovirus for therapeutic and prophylactic treatment of tumor diseases, along with methods for producing the pharmaceutical composition.
Career Highlights
Sorin Armeanu-Ebinger has worked at prestigious institutions such as Eberhard Karls Universität Tuebingen and Universitätsklinikum Tübingen. His research has been instrumental in exploring new avenues for cancer treatment, showcasing his commitment to improving patient outcomes through innovative solutions.
Collaborations
Throughout his career, he has collaborated with esteemed colleagues, including Ulrich Manfred Lauer and Michael Bitzer. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Sorin Armeanu-Ebinger stands out as a dedicated inventor in the medical field, particularly in the area of tumor treatment. His innovative patents reflect his commitment to advancing healthcare solutions and improving the lives of patients facing cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile